Characteristics of Phenotypic and Genetic Properties of Francisella tularensis 15 NIIEG Vaccine Strain with an Extended Storage Period

Investigated have been cultural-morphological, biochemical and genetic properties of lyophilized cultures of F. tularensis 15 NIIEG vaccine strain, accumulated within 60-years term and deposited at the State Collection of Pathogenic Microorganisms of Scientific Center on Expertise of Medical Application Products. The studies undertaken have demonstrated that storing of the strains in such a form at low temperatures, does not prevent changes of their genetic and phenotypic properties to the full extent. It is established that F. tularensis 15 NIIEG strain lyophilized in 1953, 1966, 1969, 2003 and 2012 maintains its immunogenic properties when cultivated on nutrient media Ft-agar with or without addition of blood, based on dissociation rates (87-99 %) of SR-colonies. While F. tularensis 15 NIIEG strain 1990 contains specified amounts (not less than 80 %) of immunogenic colonies if cultivated on nutrient media with the addition of blood, and fails to meet the requirements - if cultivated without. Identified in F. tularensis 15 NIIEG strain 1987 SR-colony decrement of 70-75 % in case of cultivation with or without addition of blood testifies to the deterioration of its immunogenic properties. RAPD and ERIC typing has showed high stability of the genome of F. tularensis 15 NIIEG cultures lyophilized at different times. Tularemia microbe vaccine strain has unique RAPD and ERIC profiles, insignificant alteration of which is observed upon storage of pathogen subculture in the dried from.

вакцинный штамм Francisella tularensis 15 НИИЭГ, культурально-морфологические, биохимические и генетические свойства, диссоциация, F tularensis 15 NIIEG vaccine strain, cultural-morphological, biochemical and genetic properties, dissociation

1. Kislichkin N.N., Kislichkina O.I. [Live tularemia vaccine Nik-sp. Francisella tularensis]. RF Patent 2308969. 27.10.2007.

2. Meshcheryakova I.S. [Tularemia: modern epidemiology and preventive vaccination (To the 80th Anniversary since the first tularemia laboratory foundation in Russia]. Epidemiol. Vaktsinoprof. 2010; 2:17–22.

3. Nikiforov V.V., Karetkina G.N. [Tularemia: since the discovery up to the present day]. Infek. Bol. 2007; 5(1):67–76.

4. Olsuf’ev N.G. [Tularemia]. M.; 1960. 459 p.

5. Sayapina L.V., Solov’ev E.A., Goryaev A.A., Bondarev V.P. [Studies of immunobiological properties in Francisella tularensis vaccine strain 15 NIIEG under extended storage conditions]. Probl. Osobo Opasn. Infek. 2015; 2:87–91.

6. Sirotyuk L.V. [Biological properties of tularemia vaccine strains NIIEG]. Zh. Mikrobiol. Epidemiol. Immunobiol. 1964; 10:116–20.

7. Trankvilevsky D.V., Udovikov A.I., Popov V.P., Zakharov K.S., Popov N.V., Bezsmertny V.E. [Situation on rodents abundance and epidemiological situation on tularemia in the territory of the Russian Federation in the second half of 2014, and prognosis for 2015]. Probl. Osobo Opasn. Infek. 2015; 1:30–5.

8. Ellis J., Oyston P.C.F., Green M., Titball R.W. Tularemia. Clin. Microbiol. Rev. 2002; 15(40):631–46.

9. Cole L.E., Elkins K.L., Michalek S.M., Qureshi N., Eaton L.J., Rallabhandi P., Cuesta N., Vogel, S.N. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J. Immunol. 2006; 176:6888–99.

10. de la Puente-Redondo V.A., del Blanco N.G., Gutiérrez-Martín C.B., García-Peña F.J., Rodríguez Ferri E.F. Comparison of different PCR approaches for typing of Francisella tularensis strains. J. Clin. Microbiol. 2000; 38(3):1016–22.